You are here: Industry Insights > drug review

News List

Why Drug regulatory authority updates their Rules and Regulations Muhammad Asim Niazi
March 21, 2023
Pharmaceutical regulatory authorities regularly update their rules and regulations regarding drug review and approval.
Monthly Pharma News Review of PharmaSources (February) - Chinese Drug review and approval Caicai/PharmaSources
March 14, 2023
The anti-PD-L1 monoclonal antibody Adebrelimab from Hengrui Pharmaceuticals was approved for marketing, and the Class 3 chemotherapy Limaprost tablets from Sino Biopharm were approved for marketing.
Weekly Pharma News Review | PharmaSources.com （Feb.6th - 10th, 2023） Caicai
February 13, 2023
A new indication of Pfizer's tofacitinib sustained release tablet was approved in China; Phase III study of obesity indication of Eli Lilly's Tirzepatide succeeded in China.
Weekly Pharma News Review | PharmaSources.com (1114-1118) PharmaSources.com
November 21, 2022
The news review of this week is from November 14 to 18, covering a total of 23 pieces of information in 3 sections, i.e., drug review, R&D, and business.
Weekly Pharma News Review | PharmaSources.com (1107-1111) PharmaSources.com
November 14, 2022
The news review of this week is from November 7 to 11, covering a total of 26 pieces of information in 3 sections, i.e., drug review, R&D, and business.
Weekly Pharma News Review | PharmaSources.com (1031-1104) PharmaSources.com
November 08, 2022
The news review of this week is from October 31 to November 4, covering a total of 25 pieces of information in 3 sections, i.e., drug review, R&D, and business.
Weekly Pharma News Review | PharmaSources.com (1024-1028) PharmaSources.com
October 31, 2022
The news review of this week is from October 24 to 28, covering a total of 23 pieces of information in 4 sections, i.e., drug review, R&D, business and listing.
Weekly Pharma News Review | PharmaSources.com (1017-1021) PharmaSources.com
October 24, 2022
The news review of this week is from October 17 to 21, covering a total of 21 pieces of information in 3 sections, i.e., drug review, R&D, and listing.
Weekly Pharma News Review | PharmaSources.com (1008-1014) PharmaSources.com
October 18, 2022
The most exciting thing for the industry is the first-in-class drug, Dorzagliatin Tablets, which is independently researched and developed by Hua Medicine was approved for marketing, becoming the first approved new drug for GKA diabetes in the world.
Weekly Pharma News Review | PharmaSources.com (0926-0930) PharmaSources.com
October 08, 2022
The news reviewed this week is from September 26 to 30, covering a total of 26 pieces of information in 4 sections, i.e. drug review, R&D, business and policy.

Previous page 1 2 3 Next page